Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 17)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199  View Abstract
6-Feb-10Reuters Investment ProfileN/ASeraCare Life Sciences Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
2-Feb-10Wright ReportsN/AWright Investors Service Comprehensive Report for SeraCare Life Sciences, Inc.42$65  View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SERACARE LIFE SCIENCES INC5$25  View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SERACARE LIFE SCIENCES INC5$25  View Abstract
18-Jan-10PriceTarget Research, Inc.N/ASeracare Life Sci has a current Overall Rating of B (Positive).7$25  View Abstract
17-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SERACARE LIFE SCIENCES INC5$25  View Abstract
13-Jan-10Life Science AnalyticsLife Science AnalyticsSeraCare Life Sciences Inc-Company Report20$150  View Abstract
5-Jan-10Global Markets DirectGlobal Markets DirectSeraCare Life Sciences, Inc. Financial and Strategic Analysis Review30$300  View Abstract
Next 7

Independent Reports (Showing 1 to 10 of 17)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199View Abstract
6-Feb-10Reuters Investment ProfileN/ASeraCare Life Sciences Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
2-Feb-10Wright ReportsN/AWright Investors Service Comprehensive Report for SeraCare Life Sciences, Inc.42$65View Abstract
31-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SERACARE LIFE SCIENCES INC5$25View Abstract
24-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SERACARE LIFE SCIENCES INC5$25View Abstract
18-Jan-10PriceTarget Research, Inc.N/ASeracare Life Sci has a current Overall Rating of B (Positive).7$25View Abstract
17-Jan-10TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: SERACARE LIFE SCIENCES INC5$25View Abstract
13-Jan-10Life Science AnalyticsLife Science AnalyticsSeraCare Life Sciences Inc-Company Report20$150View Abstract
5-Jan-10Global Markets DirectGlobal Markets DirectSeraCare Life Sciences, Inc. Financial and Strategic Analysis Review30$300View Abstract
Next 7

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.